Skip to main content
logo
Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
36.76
+0.68 (1.88%)
At close: Apr 2, 2026, 4:00 PM EDT
36.78
+0.02 (0.05%)
After-hours: Apr 2, 2026, 7:22 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
891.30M938.50M
United States Revenue Growth
-5.03%20.68%
Germany Revenue
297.00M310.70M
Germany Revenue Growth
-4.41%10.37%
Rest of Europe Revenue
950.20M873.00M
Rest of Europe Revenue Growth
8.84%24.77%
China Revenue
475.80M471.20M
China Revenue Growth
0.98%-10.77%
Rest of Asia Pacific Revenue
552.60M518.50M
Rest of Asia Pacific Revenue Growth
6.58%12.50%
Total Asia Pacific Revenue
1.03B989.70M
Total Asia Pacific Revenue Growth
3.91%0.07%
Other Countries Revenue
269.60M254.50M
Other Countries Revenue Growth
5.93%17.50%
Revenue (Total)
3.44B3.37B
Revenue (Total) Growth
2.08%13.56%

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BSI BioSpin Revenue
878.80M905.70M
BSI BioSpin Revenue Growth
-2.97%13.43%
BSI CALID Revenue
1.21B1.09B
BSI CALID Revenue Growth
10.67%13.86%
BSI Life Science Revenue
2.09B2.00B
BSI Life Science Revenue Growth
4.49%13.66%
BSI Nano Revenue
1.08B1.10B
BSI Nano Revenue Growth
-1.27%16.61%
Total BSI Revenue
3.17B3.10B
Total BSI Revenue Growth
2.45%14.69%
BEST Revenue
270.90M283.00M
BEST Revenue Growth
-4.28%0.82%
Eliminations from Revenue
-7.70M-14.10M
Revenue (Total)
3.44B3.37B
Revenue (Total) Growth
2.08%13.56%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BSI BioSpin Operating Income
104.30M157.80M
BSI BioSpin Operating Income Growth
-33.90%-19.45%
BSI CALID Operating Income
153.30M180.00M
BSI CALID Operating Income Growth
-14.83%-14.00%
BSI Life Science Operating Income
257.60M337.80M
BSI Life Science Operating Income Growth
-23.74%-16.63%
BSI Nano Operating Income
-71.80M2.30M
BSI Nano Operating Income Growth
--97.89%
Corporate, Eliminations and Other Operating Income
-137.00M-121.90M
Total BSI Operating Income
48.80M218.20M
Total BSI Operating Income Growth
-77.64%-46.07%
BEST Operating Income
19.40M34.90M
BEST Operating Income Growth
-44.41%8.05%
Operating Income (Other)
-48.80M-218.20M
Operating Income (Total)
68.20M253.10M
Operating Income (Total) Growth
-73.05%-42.07%

Capital Expenditures

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
BSI BioSpin Capital Expenditures
11.40M22.80M
BSI BioSpin Capital Expenditures Growth
-50.00%-4.60%
BSI CALID Capital Expenditures
25.30M34.10M
BSI CALID Capital Expenditures Growth
-25.81%8.60%
BSI Life Science Capital Expenditures
36.70M56.90M
BSI Life Science Capital Expenditures Growth
-35.50%2.89%
BSI Nano Capital Expenditures
36.50M19.30M
BSI Nano Capital Expenditures Growth
89.12%38.85%
Corporate Capital Expenditures
16.00M14.80M
Corporate Capital Expenditures Growth
8.11%45.10%
Total BSI Capital Expenditures
89.20M91.00M
Total BSI Capital Expenditures Growth
-1.98%14.61%
BEST Capital Expenditures
13.80M24.30M
BEST Capital Expenditures Growth
-43.21%-11.64%
Updated Feb 12, 2026. Data Source: Fiscal.ai.